Evidence map›Paper›PMID 36356649›Full record

ArticleKidney international2023

Viral associations with kidney disease diagnosis and altered kidney metatranscriptome by kidney function.

Changjin Hong, Felix Eichinger, Mohamed G Atta, Michelle M Estrella, Derek M Fine, Michael J Ross, Christina Wyatt, Tae Hyun Hwang, Matthias Kretzler, John R Sedor and 3 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Kidney international, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Changjin HongDepartment of Quantitative Health Sciences, Cleveland Clinic, Cleveland, Ohio, USA.
Felix EichingerDepartment of Medicine, University of Michigan, Ann Arbor, Michigan, USA.
Mohamed G AttaDepartment of Medicine, Johns Hopkins University, Baltimore, Maryland, USA.
Michelle M EstrellaKidney Health Research Collaborative, Department of Medicine, University of California San Francisco, San Francisco, California, USA; Division of Nephrology, San Francisco VA Health Care System, San Francisco, CA, USA.
Derek M FineDepartment of Medicine, Johns Hopkins University, Baltimore, Maryland, USA.
Michael J RossDepartment of Medicine, Albert Einstein College of Medicine, Bronx, New York, USA.
Christina WyattDepartment of Medicine, Duke University School of Medicine, Durham, North Carolina, USA.
Tae Hyun HwangDepartment of Quantitative Health Sciences, Cleveland Clinic, Cleveland, Ohio, USA.
Matthias KretzlerDepartment of Medicine, University of Michigan, Ann Arbor, Michigan, USA.
John R SedorDepartment of Inflammation and Immunity, Cleveland Clinic, Cleveland, Ohio, USA; Department of Kidney Medicine, Cleveland Clinic, Cleveland, Ohio, USA; Department of Physiology and Biophysics, Case Western Reserve University School of Medicine, Cleveland, Ohio, USA.
John F O'TooleDepartment of Inflammation and Immunity, Cleveland Clinic, Cleveland, Ohio, USA; Department of Kidney Medicine, Cleveland Clinic, Cleveland, Ohio, USA.
Aaron W MillerDepartment of Kidney Medicine, Cleveland Clinic, Cleveland, Ohio, USA; Department of Cardiovascular and Metabolic Sciences, Cleveland Clinic, Cleveland, Ohio, USA. Electronic address: millera25@ccf.org.
Leslie A BruggemanDepartment of Inflammation and Immunity, Cleveland Clinic, Cleveland, Ohio, USA; Department of Kidney Medicine, Cleveland Clinic, Cleveland, Ohio, USA. Electronic address: bruggel@ccf.org.

Funding

The Impact of COVID-19 on People Living with Rare Diseases and Their FamiliesU2CTR002818 · NCATS · CINCINNATI CHILDRENS HOSP MED CTR · PI MICHAEL SEID · 2019 to 2026
$51.2M
VIRAL PATHOGENESIS OF HIV ASSOCIATED NEPHROPATHYP01DK056492 · NIDDK · MOUNT SINAI SCHOOL OF MEDICINE OF NYU · PI KLOTMAN, PAUL EVAN · 1999 to 2021
$27.8M
Regional Pilot And Feasibility Study Grants ProgramP30DK020572 · NIDDK · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI Mehboob A Hussain · 2013 to 2026
$24.3M
Training Program in Clinical & Translationa Research in Human Glomerular DiseaseU54DK083912 · NIDDK · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI KRETZLER, MATTHIAS · 2009 to 2023
$20.3M
Burden of Chronic Kidney Disease in HIV InfectionK23DK081317 · NIDDK · JOHNS HOPKINS UNIVERSITY · PI ESTRELLA, MICHELLE M · 2009 to 2013
$835k
Viral causes of idiopathic chronic kidney diseaseR21AI135434 · NIAID · CLEVELAND CLINIC LERNER COM-CWRU · PI BRUGGEMAN, LESLIE A · 2018 to 2019
$440k
NCATS NIH HHS U2C TR002818NIAID NIH HHS R21 AI135434NIDDK NIH HHS K23 DK081317NIDDK NIH HHS P01 DK056492NIDDK NIH HHS P30 DK020572NIDDK NIH HHS U54 DK083912
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Kidney DiseasesTranscriptomeGene Expression ProfilingHumansKidney

Identifiers

PMID36356649
PMCPMC9822862

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.